Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smarter rules for digital health: How the digital omnibus can simplify without sacrificing patient rights.

Digital health·2026
Same author

Perioperative Risk Stratification with AI-Powered Chatbots: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2026
Same author

The 2026 Multisociety Acute Pulmonary Embolism Guidelines: An Expert Perspective.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Helicopter emergency medical services for interfacility transfers: an Italian expert consensus.

Scandinavian journal of trauma, resuscitation and emergency medicine·2026
Same author

Mechanical Thrombectomy for Intermediate- and High-Risk Pulmonary Embolism: A Retrospective Observational Cohort Study.

Journal of intensive care medicine·2026
Same author

Identification of physiological clusters in acute hypoxemic respiratory failure patients undergoing non-invasive respiratory support using EIT-based t-SNE and spectral clustering.

Intensive care medicine experimental·2026

Related Experiment Video

Updated: May 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Machine Learning in Postcardiotomy Shock: Implications for Temporary Mechanical Circulatory Support.

Jay S Saggu1, Harrison R Herrera2, Zhide Meng1

  • 1Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, MA.

Journal of Cardiothoracic and Vascular Anesthesia
|May 26, 2026
PubMed
Summary
This summary is machine-generated.

Machine learning (ML) aids clinical decisions for postcardiotomy shock (PCS) patients needing temporary mechanical circulatory support (tMCS). While promising for risk stratification and weaning, ML requires more validation for safe implementation.

Keywords:
V-A ECMOcardiogenic shockmachine learningperioperative critical carepostcardiotomy shocktemporary mechanical circulatory support

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Area of Science:

  • Cardiology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Postcardiotomy shock (PCS) is a critical complication post-cardiac surgery, requiring timely decisions on temporary mechanical circulatory support (tMCS).
  • Traditional risk scores have limitations in managing the complexity of PCS.
  • Machine learning (ML) offers a novel approach to integrate extensive perioperative data for improved clinical decision-making.

Purpose of the Study:

  • To review the current applications of ML across the entire PCS continuum.
  • To summarize essential ML model development aspects, including validation and implementation.
  • To highlight the potential and limitations of ML in PCS management.

Main Methods:

  • This study is a narrative expert review.
  • It evaluates ML applications in risk recognition, phenotyping, tMCS initiation, management, liberation, and prognostication.
  • Key aspects of ML model development, such as feature selection and external validation, are summarized.

Main Results:

  • ML shows current strength in risk stratification, mortality prediction, and weaning support, especially in venoarterial extracorporeal membrane oxygenation (VA-ECMO) cohorts.
  • Most existing ML models are retrospective and lack validation in PCS-specific populations.
  • Automated device titration using ML is an emerging but preclinical area.

Conclusions:

  • ML can augment, but not replace, clinician judgment in PCS management.
  • High-quality, PCS-specific datasets and prospective validation are crucial for future ML advancements.
  • Safe, transparent, and equitable implementation requires robust governance frameworks and seamless clinical workflow integration.